If not, it looks like they have to wait until 2028 at least and likely until 2032
TB-4 frag has gained increased attention in the field of tissue repair and regeneration, as it may help in reducing inflammation, wound healing, and cell migration
10.1186/s12872-024-04232-z 62 YanX.WangX.ZhangJ.MingZ.ZhangC.MaP.et al (2024)
This can happen with deeper injections, such intramuscular or intravenous injections
Proteolytic activation of latent PPOs with trypsin has been reported for broad bean PPO 46 , paraguaya peach PPO 47 , spinach PPO 48 , loquat fruit PPO 49 , beet root PPO 19 , grape PPO 50 and apple PPO 21
no consistent signal for organ toxicity or long-term harm across decades of use Special Populations: Clinical experience exists in elderly patients with dementia and stroke patients, populations where safety data is particularly valuable IV Administration Considerations: Requires clinical administration setting for intravenous dosing, which limits convenience but ensures medical oversight Dihexa: Unknown Human Safety Profile Dihexa has never been administered to humans in any controlled setting, creating a complete absence of human safety data: No Human Pharmacokinetics: Absorption, distribution, metabolism, and excretion parameters are unknown in humans Theoretical c-Met Oncogenesis Concern: The c-Met/HGF pathway is implicated in cancer progression aberrant c-Met signaling promotes tumor growth, metastasis, and angiogenesis in multiple cancer types
